Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia

PHASE2RecruitingINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

October 19, 2019

Primary Completion Date

October 19, 2029

Study Completion Date

October 19, 2029

Conditions

KeratoconusPellucid Marginal Corneal DegenerationCorneal Ectasia

Interventions

COMBINATION_PRODUCT

PXL-330 Platinum device for crosslinking with Peschke riboflavin solution

Riboflavin will be used to load the cornea, followed by UV-A crosslinking of the cornea

Trial Locations (1)

RECRUITING

Goodman Eye Center, San Francisco

All Listed Sponsors

lead

Goodman Eye Center

OTHER